BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of $431.95 million. The enterprise value is $363.82 million.
Important Dates
The next estimated earnings date is Tuesday, March 10, 2026, before market open.
| Earnings Date | Mar 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 39.15 million shares outstanding. The number of shares has increased by 20.96% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 39.15M |
| Shares Change (YoY) | +20.96% |
| Shares Change (QoQ) | -3.43% |
| Owned by Insiders (%) | 18.11% |
| Owned by Institutions (%) | 20.14% |
| Float | 24.79M |
Valuation Ratios
The trailing PE ratio is 69.13 and the forward PE ratio is 55.86.
| PE Ratio | 69.13 |
| Forward PE | 55.86 |
| PS Ratio | 8.80 |
| Forward PS | 2.17 |
| PB Ratio | 6.17 |
| P/TBV Ratio | 6.17 |
| P/FCF Ratio | 23.55 |
| P/OCF Ratio | 19.39 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 85.62, with an EV/FCF ratio of 19.84.
| EV / Earnings | 58.23 |
| EV / Sales | 7.41 |
| EV / EBITDA | 85.62 |
| EV / EBIT | 128.20 |
| EV / FCF | 19.84 |
Financial Position
The company has a current ratio of 3.19, with a Debt / Equity ratio of 0.10.
| Current Ratio | 3.19 |
| Quick Ratio | 2.91 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 1.43 |
| Debt / FCF | 0.37 |
| Interest Coverage | 1.54 |
Financial Efficiency
Return on equity (ROE) is 10.95% and return on invested capital (ROIC) is 195.88%.
| Return on Equity (ROE) | 10.95% |
| Return on Assets (ROA) | 1.92% |
| Return on Invested Capital (ROIC) | 195.88% |
| Return on Capital Employed (ROCE) | 3.26% |
| Weighted Average Cost of Capital (WACC) | 6.12% |
| Revenue Per Employee | $409,117 |
| Profits Per Employee | $52,067 |
| Employee Count | 120 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 3.04 |
Taxes
In the past 12 months, BrainsWay has paid $657,000 in taxes.
| Income Tax | 657,000 |
| Effective Tax Rate | 9.51% |
Stock Price Statistics
The stock price has increased by +122.56% in the last 52 weeks. The beta is 0.29, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | +122.56% |
| 50-Day Moving Average | 20.03 |
| 200-Day Moving Average | 14.87 |
| Relative Strength Index (RSI) | 49.06 |
| Average Volume (20 Days) | 125,911 |
Short Selling Information
| Short Interest | 130,715 |
| Short Previous Month | 60,376 |
| Short % of Shares Out | 1.05% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.17 |
Income Statement
In the last 12 months, BrainsWay had revenue of $49.09 million and earned $6.25 million in profits. Earnings per share was $0.13.
| Revenue | 49.09M |
| Gross Profit | 36.78M |
| Operating Income | 2.84M |
| Pretax Income | 6.91M |
| Net Income | 6.25M |
| EBITDA | 4.25M |
| EBIT | 2.84M |
| Earnings Per Share (EPS) | $0.13 |
Full Income StatementBalance Sheet
The company has $70.46 million in cash and $6.75 million in debt, with a net cash position of $63.71 million or $1.63 per share.
| Cash & Cash Equivalents | 70.46M |
| Total Debt | 6.75M |
| Net Cash | 63.71M |
| Net Cash Per Share | $1.63 |
| Equity (Book Value) | 70.07M |
| Book Value Per Share | 1.79 |
| Working Capital | 56.94M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $22.27 million and capital expenditures -$3.93 million, giving a free cash flow of $18.34 million.
| Operating Cash Flow | 22.27M |
| Capital Expenditures | -3.93M |
| Free Cash Flow | 18.34M |
| FCF Per Share | $0.47 |
Full Cash Flow StatementMargins
Gross margin is 74.92%, with operating and profit margins of 5.78% and 12.73%.
| Gross Margin | 74.92% |
| Operating Margin | 5.78% |
| Pretax Margin | 14.06% |
| Profit Margin | 12.73% |
| EBITDA Margin | 8.65% |
| EBIT Margin | 5.78% |
| FCF Margin | 37.36% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.96% |
| Shareholder Yield | -20.96% |
| Earnings Yield | 1.45% |
| FCF Yield | 4.25% |
Analyst Forecast
The average price target for BrainsWay is $26.50, which is 19.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $26.50 |
| Price Target Difference | 19.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BrainsWay has an Altman Z-Score of 2.82 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.82 |
| Piotroski F-Score | 5 |
